{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:24:45Z","timestamp":1789529085516,"version":"build-2803163510"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T00:00:00Z","timestamp":1461110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005549","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T13:30:01Z","timestamp":1461159001000},"page":"e1005549","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination"],"prefix":"10.1371","volume":"12","author":[{"given":"Jill M.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose J.","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Shannon-Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Leese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B.","family":"Rickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students","volume":"207","author":"HH Balfour Jr.","year":"2013","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"LS Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref3","first-page":"1898","article-title":"Fields Virology","author":"R Longnecker","year":"2013"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"DM Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-barr virus infection and multiple sclerosis: a review","volume":"5","author":"A Ascherio","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"issue":"Suppl 2","key":"ref6","doi-asserted-by":"crossref","first-page":"B194","DOI":"10.1016\/j.vaccine.2012.09.041","article-title":"The need and challenges for development of an Epstein-Barr virus vaccine","volume":"31","author":"JI Cohen","year":"2013","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.02.005","article-title":"Progress, prospects, and problems in Epstein-Barr virus vaccine development","volume":"6C","author":"HH Balfour Jr.","year":"2014","journal-title":"Curr Opin Virol"},{"key":"ref8","first-page":"2655","article-title":"Fields Virology","author":"AB Rickinson","year":"2007"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2014.04.004","article-title":"Co-infections, inflammation and oncogenesis: future directions for EBV research","volume":"26","author":"AB Rickinson","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","article-title":"Epstein-Barr virus entry","volume":"81","author":"LM Hutt-Fletcher","year":"2007","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/318287a0","article-title":"Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine","volume":"318","author":"MA Epstein","year":"1985","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults","volume":"25","author":"M Moutschen","year":"2007","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"EM Sokal","year":"2007","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1002308","DOI":"10.1371\/journal.ppat.1002308","article-title":"Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge","volume":"7","author":"J Sashihara","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"SL Elliott","year":"2008","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"M Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20051287","article-title":"Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins","volume":"203","author":"D Adhikary","year":"2006","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1371\/journal.pone.0000583","article-title":"Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy","volume":"2","author":"D Adhikary","year":"2007","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.1100590","article-title":"Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition","volume":"187","author":"HM Long","year":"2011","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.20041542","article-title":"CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells","volume":"201","author":"VA Pudney","year":"2005","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.1301629","article-title":"CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response","volume":"191","author":"RJ Abbott","year":"2013","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1371\/journal.pbio.0030404","article-title":"Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis","volume":"3","author":"M Altmann","year":"2005","journal-title":"PLoS Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/JVI.01416-06","article-title":"Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes","volume":"81","author":"W Wen","year":"2007","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejcb.2011.01.014","article-title":"Human B cells on their route to latent infection\u2014early but transient expression of lytic genes of Epstein-Barr virus","volume":"91","author":"M Kalla","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1002704","DOI":"10.1371\/journal.ppat.1002704","article-title":"The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination","volume":"8","author":"S Jochum","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"E1396","DOI":"10.1073\/pnas.1115906109","article-title":"RNAs in Epstein-Barr virions control early steps of infection","volume":"109","author":"S Jochum","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.185.9.1605","article-title":"Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response","volume":"185","author":"NM Steven","year":"1997","journal-title":"J Exp Med"},{"key":"ref28","first-page":"2603","article-title":"Fields Virology","author":"E Kieff","year":"2007"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/eji.1830250536","article-title":"Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression","volume":"25","author":"M Rowe","year":"1995","journal-title":"Eur J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.0713607","article-title":"Cyclical expression of EBV latent membrane protein 1 in EBV-transformed B cells underpins heterogeneity of epitope presentation and CD8+ T cell recognition","volume":"182","author":"JM Brooks","year":"2009","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"AD Hislop","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4049\/jimmunol.165.1.573","article-title":"CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells","volume":"165","author":"SP Lee","year":"2000","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2003-03-0930","article-title":"Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1","volume":"103","author":"E Landais","year":"2004","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2014.10.030","article-title":"Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA","volume":"474","author":"RJ Tierney","year":"2015","journal-title":"Virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.00108-09","article-title":"Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification","volume":"83","author":"C Shannon-Lowe","year":"2009","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1000341","DOI":"10.1371\/journal.ppat.1000341","article-title":"An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp\/BHRF1 link","volume":"5","author":"GL Kelly","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1128\/JVI.61.12.3870-3878.1987","article-title":"Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines","volume":"61","author":"J Finke","year":"1987","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.165.12.7078","article-title":"The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1","volume":"165","author":"N Blake","year":"2000","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ijc.10309","article-title":"Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2","volume":"99","author":"P Meij","year":"2002","journal-title":"Int J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1182\/blood-2009-02-203687","article-title":"Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation","volume":"113","author":"C Smith","year":"2009","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.176.1.157","article-title":"Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies","volume":"176","author":"RJ Murray","year":"1992","journal-title":"J Exp Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.176.1.169","article-title":"Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development","volume":"176","author":"R Khanna","year":"1992","journal-title":"J Exp Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1099\/vir.0.82519-0","article-title":"Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells","volume":"88","author":"Y Ito","year":"2007","journal-title":"J Gen Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.4049\/jimmunol.1102462","article-title":"EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail","volume":"190","author":"BD Griffin","year":"2013","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/JVI.79.8.4896-4907.2005","article-title":"CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines","volume":"79","author":"HM Long","year":"2005","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1099\/vir.0.81153-0","article-title":"Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth","volume":"86","author":"C Shannon-Lowe","year":"2005","journal-title":"J Gen Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1099\/vir.0.81906-0","article-title":"Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays","volume":"87","author":"AI Bell","year":"2006","journal-title":"J Gen Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"12362","DOI":"10.1128\/JVI.06059-11","article-title":"Epstein-Barr virus BamHI W repeat number limits EBNA2\/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains","volume":"85","author":"RJ Tierney","year":"2011","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.20070256","article-title":"A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates","volume":"204","author":"AD Hislop","year":"2007","journal-title":"J Exp Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.158.7.3325","article-title":"Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy","volume":"158","author":"SP Lee","year":"1997","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1128\/JVI.75.18.8649-8659.2001","article-title":"Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses","volume":"75","author":"A Leen","year":"2001","journal-title":"J Virol"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T14:29:44Z","timestamp":1692282584000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005549"}},"subtitle":[],"editor":[{"given":"Stephen","family":"Gottschalk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,20]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005549","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,20]]}}}